Inventor
SALVATORE BELLINVIA
Inventor
CH
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07CAcyclic or carbocyclic compounds24%
C07DHeterocyclic compounds14%
C12NMicroorganisms or enzymes5%
PatentTitleYear
12,577,256Aryl receptor modulators and methods of making and using the same202612,291,494Methods of treating fibrosis202512,071,623IL-34 antisense agents and methods of using same202412,012,418Aryl receptor modulators and methods of making and using the same202411,753,365Methods of treating fibrosis202311,427,600Aryl receptor modulators and methods of making and using the same2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to NOGRA PHARMA LTD (6)· patent assignee history
2022–2026Based in CH· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOGRA PHARMA LTD | 6 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| CH | 6 | 2022–2026 |